Bo (Alice) Du
Senior International Associate
Bo (Alice) Du joined Ropes & Gray's life sciences, regulatory and compliance practice group in the Shanghai office in 2021. She advises pharmaceutical, biotechnology, medical device and health care companies on a wide range of regulatory and compliance matters, including cross-border collaboration, market access and commercialization strategies, and post-market compliance. She also assists clients in conducting regulatory due diligence on investment targets and prospective business partners in China.
Prior to joining Ropes & Gray, Alice worked at a leading PRC law firm in its Beijing office and Shanghai office for about six years, where she advised many renowned domestic and foreign clients on corporate compliance matters, including in particular antitrust compliance and data compliance related matters. Alice passed the PRC Bar Exam.
Experience
Some representative cases in which Alice has been involved prior to joining the firm include:
- Represented multiple international pharmaceutical companies in the PRC merger filing for their concentration transactions
- Represented multiple large internet companies in SAMR’s Anti-monopoly investigations
- Represented multiple international companies in NDRC’s Anti-monopoly investigations
- Advised many multinational clients on various competition compliance issues
- Assisted a leading multinational pharmaceutical company in conducting internal investigations and audits of employee behavior
- Provided compliance review services for multiple international companies regarding cross-border data transfers
Publications
- Contributor, “The Global Landscape of Digital Health,” International Comparative Legal Guides: Digital Health Laws and Regulations 2023 (March 17, 2023)
- Co-author, “A Cross-Border Regulatory and Public Policy Analysis of Machine Learning and Artificial Intelligence: The Future of AI in Life Sciences,” Intellectual Property & Technology Law Journal (November-December 2022)
- Co-author, “Artificial Intelligence in Life Sciences,” Intellectual Property & Technology Law Journal (October 28, 2022)
- Co-author, “Global Trends in Regulatory Compliance Challenges in Advertising and Promotion,” International Comparative Legal Guides Pharmaceutical Advertising Laws and Regulations 2022
Education
- Juris Master (Competition Law), Peking University, 2015
- BA (International Economics and Trade), University of International Business and Economics, 2012